Davita - West Joliet is a medicare approved dialysis facility center in Joliet, Illinois and it has 29 dialysis stations. It is located in Will county at 1051 Essington Road Suite 160, Joliet, IL, 60435. You can reach out to the office of Davita - West Joliet at (815) 725-3275. This dialysis clinic is managed and/or owned by Davita. Davita - West Joliet has the following ownership type - Profit. It was first certified by medicare in November, 2012. The medicare id for this facility is 142742 and it accepts patients under medicare ESRD program.
| Name | Davita - West Joliet |
|---|---|
| Location | 1051 Essington Road Suite 160, Joliet, Illinois |
| No. of Dialysis Stations | 29 |
| Medicare ID | 142742 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1051 Essington Road Suite 160, Joliet, Illinois, 60435 | |
| (815) 725-3275 | |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
| NPI Number | 1134489917 |
| Organization Name | Renal Center West Joliet |
| Doing Business As | Total Renal Care Inc |
| Address | 1051 Essington Rd Ste 160 Joliet, Illinois, 60435 |
| Phone Number | (815) 725-3275 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 69% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 13% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 18% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 62% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 16% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 14% |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 65% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 17% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 18% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 62% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 30% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 8% | 12% |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 77% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 23% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 70% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 21% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 9% | 12% |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 84 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 19 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 139 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1255 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 11 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 89 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 100 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - West Joliet with elevated calcium levels.
| Patients with hypercalcemia | 155 |
| Hypercalcemia patient months | 1409 |
| Patients with Serumphosphor | 162 |
| Patients with Serumphosphor less than 3.5 mg/dL | 5 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 23 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 18 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 126 |
| Patient months included in arterial venous fistula and catheter summaries | 1007 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 75 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 4 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 148 |
| Hospitalization Rate in facility | 204.6 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 310.3 |
| Hospitalization Rate: Lower Confidence Limit | 143.6 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - West Joliet were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 32.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 43.6 |
| Readmission Rate: Lower Confidence Limit | 23.5 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - West Joliet get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.75 (As Expected) |
| SIR: Upper Confidence Limit | 2.97 |
| SIR: Lower Confidence Limit | .95 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - West Joliet's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 119 |
| Transfusion Rate in facility | 26.4 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 59.4 |
| Transfusion Rate: Lower Confidence Limit | 13 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - West Joliet lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 747 |
| Mortality Rate in facility | 16.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 19.9 |
| Mortality Rate: Lower Confidence Limit | 13.2 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago
FMC - Home Dialysis Network Inc. Location: 95 129th Infantry Drive, Joliet, Illinois, 60435 Phone: (815) 729-1110 |
Davita - West Joliet Location: 1051 Essington Road Suite 160, Joliet, Illinois, 60435 Phone: (815) 725-3275 |
Affiliated Dialysis Of Joliet Location: 1352 Houbolt Rd, Joliet, Illinois, 60431 Phone: (815) 630-5530 |
News Archive
OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
"The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts," the Washington Post reports in an article focusing on the agency's suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development.
Despite the breadth of technological possibilities available, publishers and scientific journals have not provided adequate solutions for publication during fast moving emergencies. The UN International Strategy for Disaster Reduction has identified that "the sharing of research findings, lessons learned and best practices" are a priority in its Hyogo Framework for Action 2005-2015.
Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.
› Verified 6 days ago